Article
A four-gene signature predicts survival and anti-CTLA4 immunotherapeutic responses based on immune classification of melanoma
22 Mar 2021
Abstract excerpt
Cutaneous melanoma is the most malignant skin cancer. Biomarkers for stratifying patients at initial diagnosis and informing clinical decisions are highly sought after. Here we classified melanoma patients into three immune subtypes by single-sample gene-set enrichment analysis. We further identified a four-gene tumor immune-relevant (TIR) signature that was significantly associated with the overall survival of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
